# Oncology Tissue

> **NIH NIH P30** · JOHNS HOPKINS UNIVERSITY · 2021 · $196,500

## Abstract

ABSTRACT 
The Oncology Tissue Services (OTS) Core provides a number of technologies, services and scientific 
consultation to support the research of the Sidney Kimmel Comprehensive Cancer Center (SKCCC) members 
and other Johns Hopkins University (JHU) investigators. The Core was formerly known as the Tissue 
Microarray Core (TMA), when it provided TMA-related services, digital slide scanning and analysis, and routine 
histology services. With the addition of immunohistochemistry (IHC), immunofluorescence (IF) in situ 
hybridization (ISH) and the incorporation of the cytogenetics Core, the Core was renamed. It now provides 
traditional G-band metaphase analysis and FISH technologies, services added to this Core from a previous 
SKCCC CCSG Core. These expanded services enhance the ability of SKCCC researchers to perform tissue- 
based biomarker studies. The OTS Core has constructed greater than 826 TMAs for 55 investigators, 
containing tumor and normal tissue from most major organs. It has provided more than 80 new antibody 
workups and cored more than 2,500 blocks for RNA/DNA studies. It continues to provide essential 
cytogenetics services. Users published more than 104 manuscripts involving this resource since the last 
funding period began. In recent years, there has been tremendous growth in the service of providing tissue 
cores from FFPE tissue blocks for RNA and DNA molecular analyses. Instrumentation and expertise are 
available to automatically capture high-resolution digital images of both standard histology/IHC-based slides 
and TMA slides. The OTS Core obtained an automated slide stainer to convert laboratory discoveries of novel 
protein staining into clincal biomarkers. The Core provides Web-based software tools and two back-end 
databases (TMAJ/Spectrum) to facilitate all facets of research involving TMAs, routine slides and quantitative 
image analysis. The specific aims of this Core are: 
Aim 1: Provide affordable, high-quality histology, immunohistochemistry, cytogenetics, nucleic acid harvesting 
from tissues, digital slide scanning and analysis, and tissue microarray construction services. 
Aim 2: Identify and develop new technologies to support and speed translational research in cancer, including 
automated in situ hybridization and clinical translation of research immunohistochemistry discoveries. 
Aim 3: Support the Research Programs and respond to the needs of its users to by working with specific 
investigators on new protocols, procedures and custom procedures to meet their evolving histology, 
immunohistochemistry and slide scanning requirements. 
SKCCC Managed Core 
Reporting Period: Jan. 1, 2015, to Dec. 31, 2015

## Key facts

- **NIH application ID:** 10135893
- **Project number:** 5P30CA006973-58
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** ALAN KEITH MEEKER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $196,500
- **Award type:** 5
- **Project period:** 1997-05-07 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10135893

## Citation

> US National Institutes of Health, RePORTER application 10135893, Oncology Tissue (5P30CA006973-58). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10135893. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*